<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02679092</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-36302</org_study_id>
    <nct_id>NCT02679092</nct_id>
  </id_info>
  <brief_title>Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&amp;E at 14-19 Weeks</brief_title>
  <official_title>Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&amp;E at 14-19 Weeks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dilation and evacuation (D&amp;E) is a common surgical procedure in the U.S. Adequate
      pre-operative preparation of the uterine cervix is an important part of preventing
      complications of the procedure. Traditionally, the uterine cervix is prepared for the
      procedure using water-attracting dilators, which are placed via a speculum exam and cause
      discomfort for many women. The objective of this study is to investigate the comparative
      effectiveness of mifepristone (an oral tablet) versus dilators for cervical preparation for
      D&amp;E.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Funding changes.
  </why_stopped>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedure Time</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Measured as time from speculum insertion to removal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cervical Dilation</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured by estimate with bimanual exam and passage of largest dilator immediately prior to procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Procedure Time</measure>
    <time_frame>Measured at clinic visit and on OR day, over 2 day period</time_frame>
    <description>All time required by patient (time in clinic for cervical preparation procedures)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulty of Procedure, as reported by clinician</measure>
    <time_frame>Measured within 5 minutes after procedure</time_frame>
    <description>Using Visual Analogue Scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications/Adverse Events</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Estimated blood loss, uterine injury, infection, retained products of conception</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Perceived by Patient</measure>
    <time_frame>Intraoperatively &quot;Measured during dilator placement&quot;</time_frame>
    <description>Using Visual Analogue Scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Patient Experience</measure>
    <time_frame>Measured post-operatively (30 minutes prior to discharge)</time_frame>
    <description>Using Visual Analogue Scale (VAS)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Legally Induced Abortion Without Mention of Complication</condition>
  <arm_group>
    <arm_group_label>Dilapan (14wks 0days-15wks, 6days)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The clinician will place 1 to 2 osmotic cervical dilators (Dilapan-S) (4mm x 65mm) the day before the participant's procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dilapan (16wks 0days-18wks, 6days)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The clinician will place 3 to 5 osmotic cervical dilators (Dilapan-S) (4mm x 65mm). Patients in this arm will also receive 200 mg misoprostol PO 30-90 minutes prior to their procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mifepristone (14wks 0days-15wks, 6days)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient will be administered mifepristone (200mg) orally with juice or water by the clinician or study investigator. Patients in this arm will also receive 200 mg misoprostol PO 30-90 minutes prior to their procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mifepristone (16wks 0days-18wks, 6days)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient will be administered mifepristone (200mg) orally with juice or water by the clinician or study investigator. Patients in this arm will also receive 200 mg misoprostol PO 30-90 minutes prior to their procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>400 mcg buccal 60-90 minutes prior to procedure</description>
    <arm_group_label>Dilapan (16wks 0days-18wks, 6days)</arm_group_label>
    <arm_group_label>Mifepristone (14wks 0days-15wks, 6days)</arm_group_label>
    <arm_group_label>Mifepristone (16wks 0days-18wks, 6days)</arm_group_label>
    <other_name>Cytotec</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mifepristone</intervention_name>
    <description>200 mg PO on the day prior to D&amp;E</description>
    <arm_group_label>Mifepristone (14wks 0days-15wks, 6days)</arm_group_label>
    <arm_group_label>Mifepristone (16wks 0days-18wks, 6days)</arm_group_label>
    <other_name>Danco</other_name>
    <other_name>Mifeprex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hygroscopic cervical dilators</intervention_name>
    <description>osmotic cervical dilators inserted through the internal os</description>
    <arm_group_label>Dilapan (14wks 0days-15wks, 6days)</arm_group_label>
    <arm_group_label>Dilapan (16wks 0days-18wks, 6days)</arm_group_label>
    <other_name>Dilapan-S</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 Years Old

          -  Viable, Singleton pregnancy

          -  Voluntarily seeking abortion between 14-19 weeks gestation

          -  Able to give informed consent and comply with study protocol

          -  Fluent in English or Spanish

        Exclusion Criteria:

          -  Allergy to study drugs
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Principal Investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Planned Parenthood Mar Monte</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2016</study_first_submitted>
  <study_first_submitted_qc>February 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2016</study_first_posted>
  <last_update_submitted>April 17, 2018</last_update_submitted>
  <last_update_submitted_qc>April 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Induced Abortion</keyword>
  <keyword>Mifepristone</keyword>
  <keyword>Dilation and Evacuation</keyword>
  <keyword>Cervical Preparation</keyword>
  <keyword>Osmotic Dilators</keyword>
  <keyword>Misoprostol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
    <mesh_term>Mifepristone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

